Optos plc is a medical technology company, which is engaged in the design, development, manufacturing and marketing of ultra-wide field (UWF) retinal imaging devices. The Company provides devices to eye care professionals. Its products, Daytona and California, represents its UWF retinal imaging technology, and have been converted to desktop models. Its devices include image modalities, such as color, red-free and auto fluorescence (AF). In addition, the Daytona plus device comes with the OptosAdvance browser-based image review software, which allows for documentation, monitoring and referral processing to assist in patient management. California features fluorescein angiography (FA) and UWF imaging modality, indocyanine green angiography. The Company's devices produce UWF digital images (optomap) of approximately 82% or 200 degree of the retina. Its imaging devices for disease management and treatment support ophthalmologists and retinal specialists in the medical care market.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolLON:OPTS
CUSIPN/A
Phone+44-1383-843300
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins7.73%
Return on Equity11.38%
Return on Assets6.88%
Miscellaneous
EmployeesN/A
Outstanding Shares75,960,000
Optos (LON:OPTS) Frequently Asked Questions
What is Optos' stock symbol?
Optos trades on the London Stock Exchange (LON) under the ticker symbol "OPTS."
Has Optos been receiving favorable news coverage?
Media headlines about OPTS stock have been trending somewhat positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Optos earned a news impact score of 0.10 on Accern's scale. They also gave news articles about the company an impact score of 46.38 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.
How do I buy shares of Optos?
Shares of OPTS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How can I contact Optos?
Optos' mailing address is Queensferry House Carnegie Campus, Enterprise Way, DUNFERMLINE, KY11 8GR, United Kingdom. The company can be reached via phone at +44-1383-843300.
MarketBeat Community Rating for Optos (OPTS)
MarketBeat's community ratings are surveys of what our community members think about Optos and other stocks. Vote "Outperform" if you believe OPTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
